Clinical Role - Payer
Pharmacy Times® is a leader in providing the latest clinical updates, patient counseling tools and innovative solutions to payers, pharmacy benefit managers, formulary chairs and directors, managed care directors, quality assurance directors, and Medicaid/Medicare directors.
Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.
Analysis demonstrates affordable access to care may be a factor in patient outcomes
Pharmacists’ Roles in Addressing Oncology Biosimilar Challenges
Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
Supreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.
In an interview with Pharmacy Times, Peter Bonis, MD, said pharmacists are instrumental in making sure that patients receive drugs that are both safe and effective.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said formulary adherence in health systems is essential for several reasons.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Yet those directly involved in caring for the underserved and uninsured see its value firsthand.
Trends and comfort levels have changed among consumers, pharmacies, and payers from 2019 to 2020 as it relates to pharmacist-provided services and value-based performance programs.
Prescriptions for evidence-based cancer drugs increased under a pay-for-performance program without significantly impacting cost of care.
State Medicaid programs and other providers will need to learn more about the age distribution of autism among adults enrolled in Medicaid, in order to better serve them.